FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrea Hohmann

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Pain

Anatomy

Co-author Network

Publications

TOP 3
Jonathon D Crystal; Wesley T Alford; Wenyi Zhou; Andrea G Hohmann
Source memory in the rat.
Josée Guindon; Yvonne Lai; Sara M Takacs; Heather B Bradshaw; Andrea G Hohmann
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Laura C Gregg; Kwang-Mook Jung; István Katona; Ken Mackie; Rita Nyilas; Daniele Piomelli; Jessica M Spradley; Richard L Suplita; Masahiko Watanabe; Andreas Zimmer; Andrea G Hohmann
Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrea Hohmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jonathon D Crystal; Wesley T Alford; Wenyi Zhou; Andrea G Hohmann
Source memory in the rat.
Current biology : CB 2013;23(5):387-91.
2013: Josée Guindon; Yvonne Lai; Sara M Takacs; Heather B Bradshaw; Andrea G Hohmann
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Pharmacological research : the official journal of the Italian Pharmacological Society 2013;67(1):94-109.
2012: Laura C Gregg; Kwang-Mook Jung; István Katona; Ken Mackie; Rita Nyilas; Daniele Piomelli; Jessica M Spradley; Richard L Suplita; Masahiko Watanabe; Andreas Zimmer; Andrea G Hohmann
Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012;32(28):9457-68.
2012: Wenyi Zhou; Andrea G Hohmann; Jonathon D Crystal
Rats answer an unexpected question after incidental encoding.
Current biology : CB 2012;22(12):1149-53.
2012: Liting Deng; Josée Guindon; Alexandros Makriyannis; Ganesh A Thakur; V Kiran Vemuri; Fletcher A White; Andrea G Hohmann
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.
Molecular pain 2012;8():71.
2011: Natale R Sciolino; Wenyi Zhou; Andrea G Hohmann
Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
Pharmacological research : the official journal of the Italian Pharmacological Society 2011;64(3):226-34.
2011: Tannia Gutierrez; Alexandros Makriyannis; Alexander M Zvonok; Jonathon D Crystal; Andrea G Hohmann
Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain.
Pain 2011;152(9):1976-87.
2011: Josée Guindon; Andrea G Hohmann
The endocannabinoid system and cancer: therapeutic implication.
British journal of pharmacology 2011;163(7):1447-63.
2011: Josée Guindon; Ana Guijarro; Daniele Piomelli; Andrea G Hohmann
Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
British journal of pharmacology 2011;163(7):1464-78.
2011: Elizabeth J Rahn; Ganesh A Thakur; Jodi Anne T Wood; Alexander M Zvonok; Alexandros Makriyannis; Andrea G Hohmann
Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effects.
Pharmacology, biochemistry, and behavior 2011;98(4):493-502.
2010: Jason R Clapper; Guillermo Moreno-Sanz; Roberto Russo; Ana Guijarro; Federica Vacondio; Andrea Duranti; Andrea Tontini; Silvano Sanchini; Natale R Sciolino; Jessica M Spradley; Andrea G Hohmann; Antonio Calignano; sha mor; Giorgio Tarzia; Daniele Piomelli
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
Nature neuroscience 2010;13(10):1265-70.
2010: Jessica M Spradley; Josée Guindon; Andrea G Hohmann
Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Pharmacological research : the official journal of the Italian Pharmacological Society 2010;62(3):249-58.
2010: N R Sciolino; M Bortolato; S A Eisenstein; J Fu; F Oveisi; Andrea G Hohmann; Daniele Piomelli
Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats.
Neuroscience 2010;168(2):371-86.
2010: Elizabeth J Rahn; Alexander M Zvonok; Alexandros Makriyannis; Andrea G Hohmann
Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation.
The AAPS journal 2010;12(2):147-57.
2010: Sarah A Eisenstein; Jason R Clapper; Philip V Holmes; Daniele Piomelli; Andrea G Hohmann
A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.
Pharmacological research : the official journal of the Italian Pharmacological Society 2010;61(5):419-29.
2009: Josée Guindon; Andrea G Hohmann
The endocannabinoid system and pain.
CNS & neurological disorders drug targets 2009;8(6):403-21.
2009: Sarah A Eisenstein; Philip V Holmes; Andrea G Hohmann
Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation.
Synapse (New York, N.Y.) 2009;63(11):941-50.
2009: Elizabeth J Rahn; Andrea G Hohmann
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2009;6(4):713-37.
2009: Rita Nyilas; Laura C Gregg; Ken Mackie; Masahiko Watanabe; Andreas Zimmer; Andrea G Hohmann; István Katona
Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.
The European journal of neuroscience 2009;29(10):1964-78.
2009: Praveen Anand; Garth Whiteside; Christopher J Fowler; Andrea G Hohmann
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
Brain research reviews 2009;60(1):255-66.
2008: Elizabeth J Rahn; Alexander M Zvonok; Ganesh A Thakur; Atmaram D Khanolkar; Alexandros Makriyannis; Andrea G Hohmann
Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.
The Journal of pharmacology and experimental therapeutics 2008;327(2):584-91.
2008: Anna M Moise; Sarah A Eisenstein; Giuseppe Astarita; Daniele Piomelli; Andrea G Hohmann
An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
Psychopharmacology 2008;200(3):333-46.
2008: J Guindon; Andrea G Hohmann
A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism.
British journal of pharmacology 2008;153(7):1341-3.
2008: J Guindon; Andrea G Hohmann
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.
British journal of pharmacology 2008;153(2):319-34.
2008: Richard L Suplita; Sarah A Eisenstein; Mark H Neely; Anna M Moise; Andrea G Hohmann
Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia.
Neuropharmacology 2008;54(1):161-71.
2007: E J Rahn; Alexandros Makriyannis; Andrea G Hohmann
Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
British journal of pharmacology 2007;152(5):765-77.
2007: Andrea G Hohmann
Inhibitors of monoacylglycerol lipase as novel analgesics.
British journal of pharmacology 2007;150(6):673-5.
2007: Tannia Gutierrez; Jesse N Farthing; Alexander M Zvonok; Alexandros Makriyannis; Andrea G Hohmann
Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
British journal of pharmacology 2007;150(2):153-63.
2006: Jesse LoVerme; Roberto Russo; Giovanna La Rana; Jin Fu; Jesse Farthing; Giuseppina Mattace Raso; Rosaria Meli; Andrea G Hohmann; Antonio Calignano; Daniele Piomelli
Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.
The Journal of pharmacology and experimental therapeutics 2006;319(3):1051-61.
2006: Katherine Connell; Nathan Bolton; Daniel Olsen; Daniele Piomelli; Andrea G Hohmann
Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.
Neuroscience letters 2006;397(3):180-4.
2006: Richard L Suplita; Tannia Gutierrez; Darren Fegley; Daniele Piomelli; Andrea G Hohmann
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia.
Neuropharmacology 2006;50(3):372-9.
2006: Andrea G Hohmann; Richard L Suplita
Endocannabinoid mechanisms of pain modulation.
The AAPS journal 2006;8(4):E693-708.
2006: Andrea G Hohmann
Localization of cannabinoid CB1 receptor mRNA using ribonucleotide probes: methods for double- and single-label in situ hybridization.
Methods in molecular medicine 2006;123():71-89.
2005: Andrea G Hohmann; Mark H Neely; Jeremiah Piña; Andrea Neely
Neonatal chronic hind paw inflammation alters sensitization to intradermal capsaicin in adult rats: a behavioral and immunocytochemical study.
The journal of pain : official journal of the American Pain Society 2005;6(12):798-808.
2005: Richard L Suplita; Jesse N Farthing; Tannia Gutierrez; Andrea G Hohmann
Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.
Neuropharmacology 2005;49(8):1201-9.
2005: Andrea G Hohmann
A cannabinoid pharmacotherapy for chemotherapy-evoked painful peripheral neuropathy.
Pain 2005;118(1-2):3-5.
2005: Andrea G Hohmann; Richard L Suplita; Nathan M Bolton; Mark H Neely; Darren Fegley; Regina A Mangieri; Jocelyn F Krey; J Michael Walker; Philip V Holmes; Jonathon D Crystal; Andrea Duranti; Andrea Tontini; sha mor; Giorgio Tarzia; Daniele Piomelli
An endocannabinoid mechanism for stress-induced analgesia.
Nature 2005;435(7045):1108-12.
2005: J M Walker; Andrea G Hohmann
Cannabinoid mechanisms of pain suppression.
Handbook of experimental pharmacology 2005;(168):509-54.
2004: Andrea Neely; Alexander M Zvonok; Alexandros Makriyannis; Andrea G Hohmann
Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation.
Journal of neurophysiology 2004;92(6):3562-74.
2004: Andrea G Hohmann; Jesse N Farthing; Alexander M Zvonok; Alexandros Makriyannis
Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin.
The Journal of pharmacology and experimental therapeutics 2004;308(2):446-53.
2003: Tannia Gutierrez; Andrea Neely; Mark H Neely; Kimberly G Freeman; Gaylen L Edwards; Andrea G Hohmann
Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception.
Brain research 2003;987(2):176-85.
2003: Jonathon D Crystal; Kenneth W Maxwell; Andrea G Hohmann
Cannabinoid modulation of sensitivity to time.
Behavioural brain research 2003;144(1-2):57-66.
2003: Andrea Neely; Alexandros Makriyannis; Andrea G Hohmann
Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Neuroscience 2003;119(3):747-57.
2003: Andrea Neely; Richard L Suplita; Andrea G Hohmann
A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Neuroscience 2003;117(3):659-70.
2002: Andrea G Hohmann
Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives.
Chemistry and physics of lipids 2002;121(1-2):173-90.
2000: Mary Ann Ruda; Qing Dong Ling; Andrea G Hohmann; Yuan Bo Peng; Toshiya Tachibana
Altered nociceptive neuronal circuits after neonatal peripheral inflammation.
Science (New York, N.Y.) 2000;289(5479):628-31.
2000: Andrea G Hohmann; Miles Herkenham
Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study.
Synapse (New York, N.Y.) 2000;37(1):71-80.
1999: Andrea G Hohmann; K Tsou; J Michael Walker
Intrathecal cannabinoid administration suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in rat spinal cord: comparison with morphine.
Zhongguo yao li xue bao = Acta pharmacologica Sinica 1999;20(12):1132-6.
1999: Andreas Zimmer; AM Zimmer; Andrea G Hohmann; Miles Herkenham; Tom Bonner
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(10):5780-5.
1999: Andrea G Hohmann; EM Briley; Miles Herkenham
Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord.
Brain research 1999;822(1-2):17-25.
1999: Andrea G Hohmann; Miles Herkenham
Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study.
Neuroscience 1999;90(3):923-31.
1999: Andrea G Hohmann; K Tsou; J Michael Walker
Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat.
Journal of neurophysiology 1999;81(2):575-83.
1999: J Michael Walker; Andrea G Hohmann; WJ Martin; NM Strangman; Susan M Huang; K Tsou
The neurobiology of cannabinoid analgesia.
Life sciences 1999;65(6-7):665-73.
1999: Andrea G Hohmann; Miles Herkenham
Cannabinoid receptors undergo axonal flow in sensory nerves.
Neuroscience 1999;92(4):1171-5.
1998: NM Strangman; S L Patrick; Andrea G Hohmann; K Tsou; J Michael Walker
Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity.
Brain research 1998;813(2):323-8.
1998: Andrea G Hohmann; K Tsou; J Michael Walker
Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2.
Neuroscience letters 1998;257(3):119-22.
1998: Andrea G Hohmann; Miles Herkenham
Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment.
Neuroscience letters 1998;252(1):13-6.
1996: W J Martin; Andrea G Hohmann; J M Walker
Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(20):6601-11.
1996: K Tsou; K A Lowitz; Andrea G Hohmann; W J Martin; C B Hathaway; David A Bereiter; J Michael Walker
Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist.
Neuroscience 1996;70(3):791-8.
1995: Andrea G Hohmann; W J Martin; K Tsou; J Michael Walker
Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2.
Life sciences 1995;56(23-24):2111-8.
1994: M L Leitner; Andrea G Hohmann; S L Patrick; J Michael Walker
Regional variation in the ratio of sigma 1 to sigma 2 binding in rat brain.
European journal of pharmacology 1994;259(1):65-9.
1992: Andrea G Hohmann; Rae Reiko Matsumoto; M K Hemstreet; S L Patrick; J E Margulies; R P Hammer; J Michael Walker
Effects of 1,3-di-o-tolylguanidine (DTG), a sigma ligand, on local cerebral glucose utilization in rat brain.
Brain research 1992;593(2):265-73.
1992: J Michael Walker; Wayne D Bowen; S R Goldstein; A H Roberts; S L Patrick; Andrea G Hohmann; B DeCosta
Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study.
Brain research 1992;581(1):33-8.
1990: L A Thompson; Rae Reiko Matsumoto; Andrea G Hohmann; J Michael Walker
Striatonigral prodynorphin: a model system for understanding opioid peptide function.
Annals of the New York Academy of Sciences 1990;579():192-203.